TY - JOUR
T1 - Erratum to
T2 - Japanese phase II study of rituximab maintenance for untreated indolent B-cell non-Hodgkin lymphoma with high tumor burden (International Journal of Hematology, (2016), 104, 6, (700-708), 10.1007/s12185-016-2097-9)
AU - Igarashi, Tadahiko
AU - Ogura, Michinori
AU - Itoh, Kuniaki
AU - Taniwaki, Masafumi
AU - Ando, Kiyoshi
AU - Kuroda, Yoshiaki
AU - Yamamoto, Kazuhito
AU - Uike, Naokuni
AU - Tomita, Akihiro
AU - Nagai, Hirokazu
AU - Kurosawa, Mitsutoshi
AU - Mori, Shigeo
AU - Nawano, Shigeru
AU - Terauchi, Takashi
AU - Ohashi, Yasuo
AU - Tobinai, Kensei
N1 - Publisher Copyright:
© 2016, The Japanese Society of Hematology.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - The authors would like to correct the errors in the publication of the original article. The corrected details are given below for your reading. The Clinical trial number should be “UMIN000001603” at the end of Abstract and in the last sentence of the paragraph heading “Study design and patients” under “Materials and methods” section. Secondly, the Fig. 1 was incorrectly published with the meaningless red font. The corrected figure is given below: (Figure presented.).
AB - The authors would like to correct the errors in the publication of the original article. The corrected details are given below for your reading. The Clinical trial number should be “UMIN000001603” at the end of Abstract and in the last sentence of the paragraph heading “Study design and patients” under “Materials and methods” section. Secondly, the Fig. 1 was incorrectly published with the meaningless red font. The corrected figure is given below: (Figure presented.).
UR - https://www.scopus.com/pages/publications/84997637174
UR - https://www.scopus.com/pages/publications/84997637174#tab=citedBy
U2 - 10.1007/s12185-016-2155-3
DO - 10.1007/s12185-016-2155-3
M3 - Comment/debate
C2 - 27896571
AN - SCOPUS:84997637174
SN - 0925-5710
VL - 105
SP - 109
EP - 110
JO - International Journal of Hematology
JF - International Journal of Hematology
IS - 1
ER -